FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Olivier Lafont

Research Profile

Chemicals & Drugs

Physiology

Biotransformation

Procedures

Phenomena

Living Beings

Occupations

Pharmacy

Genes & Molecular Sequences

Molecular Structure

Concepts & Ideas

Co-author Network

Publications

TOP 3
François Estour; R K Kalakuntla; Olivier Lafont; R Le Provost; S Letort; S Müller; G Reiter; T Wille; Worek Franz; G Gouhier
Functionalized cyclodextrins bearing an alpha nucleophile--a promising way to degrade nerve agents.
Raman Kumar Kalakuntla; Olivier Lafont; Romain Le Provost; Sophie Letort; Susanne Müller; Georg Reiter; Horst Thiermann; Timo Wille; Worek Franz; Géraldine Gouhier; François Estour
New modified β-cyclodextrin derivatives as detoxifying agents of chemical warfare agents (I). Synthesis and preliminary screening: evaluation of the detoxification using a half-quantitative enzymatic assay.
Susanne Müller; Horst Thiermann; Worek Franz; François Estour; Raman Kumar Kalakuntla; Olivier Lafont; Romain Le Provost; Georg Reiter
New modified β-cyclodextrin derivatives as detoxifying agents of chemical warfare agents (II). In vitro detoxification of cyclosarin (GF): general screening and toxicokinetic aspects of OP scavengers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Olivier Lafont (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: François Estour; R K Kalakuntla; Olivier Lafont; R Le Provost; S Letort; S Müller; G Reiter; T Wille; Worek Franz; G Gouhier
Functionalized cyclodextrins bearing an alpha nucleophile--a promising way to degrade nerve agents.
Chemico-biological interactions 2013;203(1):202-7.
2013: Raman Kumar Kalakuntla; Olivier Lafont; Romain Le Provost; Sophie Letort; Susanne Müller; Georg Reiter; Horst Thiermann; Timo Wille; Worek Franz; Géraldine Gouhier; François Estour
New modified β-cyclodextrin derivatives as detoxifying agents of chemical warfare agents (I). Synthesis and preliminary screening: evaluation of the detoxification using a half-quantitative enzymatic assay.
Toxicology letters 2013;216(2-3):200-5.
2013: Susanne Müller; Horst Thiermann; Worek Franz; François Estour; Raman Kumar Kalakuntla; Olivier Lafont; Romain Le Provost; Georg Reiter
New modified β-cyclodextrin derivatives as detoxifying agents of chemical warfare agents (II). In vitro detoxification of cyclosarin (GF): general screening and toxicokinetic aspects of OP scavengers.
Toxicology letters 2013;216(2-3):206-12.
2012: Olivier Lafont
[Helen of Troy and medicine, a picture of the "Salle des Actes"].
Revue d'histoire de la pharmacie 2012;60(373):7-16.
2011: Olivier Lafont
[The opinion of Herman Boerhaave on medicines, through a non-authorized book].
Revue d'histoire de la pharmacie 2011;59(370):221-34.
2011: Olivier Lafont
[Boerhaave and medication].
Histoire des sciences médicales 2011;45(2):127-9.
2008: Olivier Lafont
[From apprenticeship to Nobel Prize: Henri Moissan's fabulous destiny].
Annales pharmaceutiques françaises 2008;66(1):28-33.
2007: François Estour; Vincent Ferranti; Christiane Chabenat; Emilie Toussaint; Hervé Galons; Olivier Lafont
Investigation of N-hydroxythalidomide in vitro stability and comparison to other N-substituted derivatives.
Journal of pharmaceutical and biomedical analysis 2007;45(2):237-42.
2007: Nicolas Masurier; Olivier Lafont; François Estour
[Substituted cyclodextrins: an example of biomimetic catalyzers].
Annales pharmaceutiques françaises 2007;65(2):126-33.
2006: Nicolas Masurier; François Estour; Bertrand Lefèvre; Bernard Brasme; Patrick Masson; Olivier Lafont
Improved access to 2-O-monobenzyl ethers of beta-cyclodextrin as precursors of catalysts for organophosphoryl esters hydrolysis.
Carbohydrate research 2006;341(7):935-40.
2005: Nicolas Masurier; François Estour; Marie-Thérèse Froment; Bertrand Lefèvre; Jean-Claude Debouzy; Bernard Brasme; Patrick Masson; Olivier Lafont
Synthesis of 2-substituted beta-cyclodextrin derivatives with a hydrolytic activity against the organophosphorylester paraoxon.
European journal of medicinal chemistry 2005;40(7):615-23.
2004: François Estour; Bernardin Akagah; J Ségrestaa; Philippe Vérité; Sabine Ménager; Olivier Lafont
[Porphyrin catalysts: a tool for preparation of metabolite models].
Annales pharmaceutiques françaises 2004;62(5):297-303.
2004: Bernardin Akagah; François Estour; Philippe Vérité; Pédro Lameiras; Mohammed Nour; Christian Cavé; Sabine Ménager; Olivier Lafont
Regio- and diastereocontrolled preparative oxidation of methyloctalones by a biomimetic porphyrin catalyst.
Chirality 2004;16(6):398-403.
2004: M Berrabah; Dominique Andre; Philippe Verite; A Zahidi; Olivier Lafont
Aminoglutethimide included in nanocapsules suspension: comparison of GC-MS and HPLC methods for control.
Journal of pharmaceutical and biomedical analysis 2004;35(4):761-8.
2003: François Estour; Sabine Ménager; Bernardin Akagah; Olivier Lafont
Comparison of the efficiency of various methods for the synthesis of models of metabolites: example of 4a-methylhexahydronaphtalenones.
European journal of medicinal chemistry 2003;38(11-12):925-8.
2002: Aida Mehmedagic; Philippe Verite; Sabine Menager; Christine Tharasse; Christiane Chabenat; Dominique Andre; Olivier Lafont
Investigation of the effects of concomitant caffeine administration on the metabolic disposition of pyrazinamide in rats.
Biopharmaceutics & drug disposition 2002;23(5):191-5.
2002: Jérôme Segrestaa; Philippe Vérité; François Estour; Sabine Ménager; Olivier Lafont
Improvement of a biomimetic porphyrin catalytic system by addition of acids.
Chemical & pharmaceutical bulletin 2002;50(6):744-8.
2002: Amar Ghaib; Sabine Ménager; Philippe Vérité; Olivier Lafont
Synthesis of variously 9,9-dialkylated octahydropyrimido [3,4-a]-s-triazines with potential antifungal activity.
Farmaco (Società chimica italiana : 1989) 2002;57(2):109-16.
2001: Vincent Ferranti; Christiane Chabenat; H Marchais; Sabine Ménager; H Hue; AM Orecchioni; Olivier Lafont
Effects of encapsulation of primidone on its oxidative metabolism in rats.
Drug metabolism and drug interactions 2001;18(3-4):191-208.
2000: M Berrabah; Dominique Andre; Philippe Verite; A Zahidi; Olivier Lafont
Preparation and evaluation of benzyl benzoate-loaded poly-epsilon-caprolactone nanoparticles.
Die Pharmazie 2000;55(4):322-3.
2000: S Chraibi-Ben Moubarik; S Menager; Olivier Lafont
Competition between the beta-hydroxylation of a primary and a tertiary carbon atom in rats.
European journal of medicinal chemistry 2000;35(1):97-105.
1999: Vincent Ferranti; H Marchais; Christiane Chabenat; AM Orecchioni; Olivier Lafont
Primidone-loaded poly-epsilon-caprolactone nanocapsules: incorporation efficiency and in vitro release profiles.
International journal of pharmaceutics 1999;193(1):107-11.
1998: Vincent Ferranti; Christiane Chabenat; Sabine Ménager; Olivier Lafont
Simultaneous determination of primidone and its three major metabolites in rat urine by high-performance liquid chromatography using solid-phase extraction.
Journal of chromatography. B, Biomedical sciences and applications 1998;718(1):199-204.
1998: H Marchais; S Benali; Juan M Irache; C Tharasse-Bloch; Olivier Lafont; AM Orecchioni
Entrapment efficiency and initial release of phenylbutazone from nanocapsules prepared from different polyesters.
Drug development and industrial pharmacy 1998;24(9):883-8.
1997: Aida Mehmedagic; Philippe Vérité; Sabine Ménager; C Tharasse; Christiane Chabenat; D André; Olivier Lafont
Determination of pyrazinamide and its main metabolites in rat urine by high-performance liquid chromatography.
Journal of chromatography. B, Biomedical sciences and applications 1997;695(2):365-72.
1996: P Vérité; C Cavé; Sabine Ménager; J Davy; D André; C C Farnoux; Olivier Lafont
Phenobarbital metabolism by hepatocytes isolated from rat.
Drug metabolism and drug interactions 1996;13(1):41-55.
1995: S Menager; C Loire; T Petrakian; C Combet Farnoux; C Delabos; J Garnier; Olivier Lafont
[Iminodimethylation, a method for pharmacomodulation in pyrimido-[3,4-a]-s-triazine series].
Annales pharmaceutiques françaises 1995;53(1):29-37.
1994: M Berrabah; D André; F Prévot; AM Orecchioni; Olivier Lafont
GC-MS determination of phenobarbitone entrapped in poly-epsilon-caprolactone nanocapsules.
Journal of pharmaceutical and biomedical analysis 1994;12(3):373-8.
1993: C La Vallée; M Lafont; Olivier Lafont
[An example of social welfare during the ancien regime: the choir school of Notre Dame de Rouen].
Revue d'histoire de la pharmacie 1993;40(297):141-9.
1992: P Vérité; D André; Sabine Ménager; Olivier Lafont
Gas chromatographic-mass spectrometric method for analysis of a pyrimido-s-triazine and some of its metabolites in dog urine.
Journal of chromatography 1992;578(1):134-40.
1991: A Talab; C Cavé; A Yebga; Sabine Ménager; C Combet Farnoux; Olivier Lafont
[Chromic oxidation and synthesis of barbiturate metabolites].
Journal de pharmacie de Belgique 1991;46(5):293-300.
1991: Olivier Lafont; M Lafont
[The personalization of relations between individuals and public authority, or: Geoffroy and the Le Tellier family].
Revue d'histoire de la pharmacie 1991;38(288):15-23.
1990: C Lacroix; J L Tranvouez; T Phan Hoang; H Duwoos; Olivier Lafont
Pharmacokinetics of pyrazinamide and its metabolites in patients with hepatic cirrhotic insufficiency.
Arzneimittel-Forschung 1990;40(1):76-9.
1990: Sabine Ménager; Olivier Lafont; P Chrétien; A Bryskier
[Preparation of monodesethylamodiaquine from human urine].
Annales pharmaceutiques françaises 1990;48(1):38-41.
1989: C Lacroix; T P Hoang; J Nouveau; C Guyonnaud; G Laine; H Duwoos; Olivier Lafont
Pharmacokinetics of pyrazinamide and its metabolites in healthy subjects.
European journal of clinical pharmacology 1989;36(4):395-400.
1989: A Talab; C Cavé; Sabine Ménager; M Miocque; Olivier Lafont
[Synthesis of potential metabolites of a barbiturate containing two branched side chains].
Annales pharmaceutiques françaises 1989;47(5):304-13.
1989: C Lacroix; A Hermelin; R Guiberteau; C Guyonnaud; J Nouveau; H Duwoos; Olivier Lafont
Haemodialysis of pyrazinamide in uraemic patients.
European journal of clinical pharmacology 1989;37(3):309-11.
1988: C Lacroix; C Guyonnaud; M Chaou; H Duwoos; Olivier Lafont
Interaction between allopurinol and pyrazinamide.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1988;1(9):807-11.
1988: Olivier Lafont; C Cave; S Menager; B Lambrey; M Miocque
Passage of allophanoyl-gamma-lactones through the kidney.
European journal of drug metabolism and pharmacokinetics 1988;13(2):77-80.
1988: C Cavé; Olivier Lafont; M Miocque
[Stability and detection of metabolites of barbiturates: 2-oxo tetrahydro-3-furoic acids].
Annales pharmaceutiques françaises 1988;46(2):111-9.
1987: C Lacroix; P Poncet; G Laine; C Guyonnaud; M Ray; S Menager; Olivier Lafont
[Microdetermination of pyrazinamide and its metabolites (pyrazinoic acid, 5-hydroxypyrazinoic acid, 5-hydroxypyrazinamide and pyrazinuric acid) in plasma and urine with liquid chromatography].
Journal of chromatography 1987;422():217-25.
1987: C Lacroix; F Cerutti; J Nouveau; S Menager; Olivier Lafont
[Determination of plasma ethambutol with liquid chromatography and ultraviolet spectrophotometry].
Journal of chromatography 1987;415(1):85-94.
1987: C Lacroix; B Langlois; Sabine Ménager; Olivier Lafont
[Simultaneous microdetermination of pyrazinamide and pyrazinoic acid by liquid chromatography].
Annales de biologie clinique 1987;45(3):297-9.
1986: C Lacroix; F Inger; S Menager; Olivier Lafont
[Simultaneous determination of urinary hippuric acid and o-, m-, p-methylhippuric acids with liquid chromatography].
Journal of chromatography 1986;382():275-9.
1985: P Guiton; S Menager; Olivier Lafont
[Permanganate oxidation of ethylbenzene in the presence of quaternary ammonium].
Annales pharmaceutiques françaises 1985;43(4):373-7.
1984: B Lambrey; Olivier Lafont; P D'Athis; C Jacquot
[Development of proxibarbal blood levels. The role of various elimination processes].
Journal de pharmacologie 1984;15(2):223-30.
1984: D Simon; Olivier Lafont; C Combet Farnoux; M Miocque; C Delabos; J Garnier; P Gayral
[Phenoxy- and phenylthiochalcones. Effect of substitution on the antifungal and antiprotozoal activity].
Annales pharmaceutiques françaises 1984;42(3):271-82.
1983: R Sarrasin; S Menager; P Colboc; M Lafont; Olivier Lafont
[Role of nuclear magnetic resonance among the methods for studying xenobiotic metabolism].
LARC médical 1983;3(1):22-3.
1982: D Simon; Olivier Lafont; J Mahuteau; M G Karmouta; C Combet Farnoux
[Iminobarbiturates: chemical displacements in d6-DMSO of double-bonded carbon atoms].
Annales pharmaceutiques françaises 1982;40(6):515-8.